--- title: "Kaisa Health Group Holdings Limited (00876.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/00876.HK.md" symbol: "00876.HK" name: "Kaisa Health Group Holdings Limited" industry: "Health Care Supplies" --- # Kaisa Health Group Holdings Limited (00876.HK) | Item | Detail | |------|--------| | Industry | Health Care Supplies | | Location | HK Market | | Website | [www.kaisahealth.com](https://www.kaisahealth.com) | ## Company Profile Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People’s Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-ca... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-16T04:30:10.000Z **Overall: C (0.59)** **Industry**: Health Care Supplies | Metric | Value | |--------|-------| | Industry Ranking | 6 / 12 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -8.46% | | | Net Profit YoY | 45.04% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.30 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1.00B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 166.39M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -6.99% | D | | Profit Margin | -18.76% | D | | Gross Margin | 36.21% | C | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -8.46% | D | | Net Profit YoY | 45.04% | B | | Total Assets YoY | -9.63% | E | | Net Assets YoY | -5.76% | D | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -533.12% | E | | OCF YoY | -8.46% | D | #### Operating Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.31 | D | #### Debt Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 16.01% | A | ```chart-data:radar { "title": "Longbridge Financial Score - Kaisa Health Group Holdings Limited", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-6.99%", "rating": "D" }, { "name": "Profit Margin", "value": "-18.76%", "rating": "D" }, { "name": "Gross Margin", "value": "36.21%", "rating": "C" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-8.46%", "rating": "D" }, { "name": "Net Profit YoY", "value": "45.04%", "rating": "B" }, { "name": "Total Assets YoY", "value": "-9.63%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-5.76%", "rating": "D" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-533.12%", "rating": "E" }, { "name": "OCF YoY", "value": "-8.46%", "rating": "D" } ] }, { "name": "Operating", "grade": "D", "indicators": [ { "name": "Turnover", "value": "0.31", "rating": "D" } ] }, { "name": "Security", "grade": "A", "indicators": [ { "name": "Gearing Ratio", "value": "16.01%", "rating": "A" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | CONANT OPTICAL (HK.2276) | A | B | B | B | B | B | | 02 | CIRC (HK.1763) | B | B | C | C | B | B | | 03 | INT MEDICAL (HK.1501) | B | B | C | B | B | B | | 04 | ORBUSNEICH (HK.6929) | B | B | C | A | C | B | | 05 | WEIGAO GROUP (HK.1066) | B | C | C | B | C | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -33.92 | 10/12 | - | - | - | | PB | 2.43 | 8/12 | 0.87 | 0.33 | 0.25 | | PS (TTM) | 6.36 | 9/12 | 2.27 | 0.76 | 0.57 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/00876.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/00876.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/00876.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.